CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis.
CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis.
复制标题
DOI:
10.1158/0008-5472.can-13-1617
复制
发表时间:
2014-02-15
期刊:
影响因子:
11.2
通讯作者:
You M
中科院分区:
文献类型:
--
作者:
James MA;Vikis HG;Tate E;Rymaszewski AL;You M
The transmembrane protein CLPTM1L is overexpressed in non-small cell lung cancer (NSCLC) where it protects tumor cells from genotoxic apoptosis. Here we show that RNAi-mediated blockade of CLPTM1L inhibits K-Ras-induced lung tumorigenesis. CLPTM1L expression was required in vitro for morphological transformation by H-RasV12 or K-RasV12, anchorage independent growth and survival of anoikis of lung tumor cells. Mechanistic investigations indicated that CLPTM1L interacts with PI3K and is essential for Ras-induced AKT phosphorylation. Further, that the anti-apoptotic protein Bcl-xL is regulated by CLPTM1L independently of AKT activation. Constitutive activation of AKT or Bcl-xL rescued the transformed phenotype in CLPTM1L-depleted cells. The CLPTM1L gene lies within a cancer susceptibility locus at chromosome 5p15.33 defined by genome-wide association studies. The risk genotype at the CLPTM1L locus was associated with high expression of CLPTM1L in normal lung tissue, suggesting that cis-regulation of CLPTM1L may contribute to lung cancer risk. Taken together, our results establish a pro-tumorigenic role for CLPTM1L that is critical for Ras-driven lung cancers, with potential implications for therapy and chemosensitization.